Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Multiple mouse desmoglein 1 isoforms have distinct roles in skin and hair development.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

Rabies virus was found in specific skin cells of rabid dogs' muzzles, suggesting these cells could help diagnose rabies.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

A new one-step test can quickly identify skin cancer during surgery.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Foreskin keratinocytes and SVK14 cells express certain cytochrome P450 enzymes, unlike hair follicle keratinocytes.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Sebaceous glands help study fatty acid transporters and binding proteins.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.